Summary
- Current Price
- As of today, NRXP price is $3.28, up +2.18% on
- Current Price All-Time High
- NRXP price is currently -99.57% below its historical high of $769.90 set on
- Market Cap
- NRXP current market cap is $108M, up +156.06% over the past 365 days
- PE Ratio
- NRXP PE ratio is unknown
- Revenue
- NRXP current annual revenue is $1.23M, up +100.00% year-over-year
- Next Earnings
- The next earnings release for NRXP is on
Profile
| Metric | Value |
|---|---|
| Full Name | NRx Pharmaceuticals, Inc. |
| Ticker | NASDAQ: NRXP |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | nrxpharma.com |
| Employees | 2 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $3.28 | ||
| Price, 1D Change | +2.18% | |
| $108M | ||
| - | ||
| - | ||
| 1.97 | ||
| $1M | ||
| Revenue, 1Y Change | +100.00% | |
| -$1.34 | ||
| EPS, 1Y Change | +43.34% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:10 | |
| Next Split | N/A | N/A |
| Last Ticker Change | BRPA | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.34 | ||
| EPS Estimate | N/A | -$0.36 |
| EPS Est. Change | N/A | +73.08% |
| $1.23M | ||
| Revenue Estimate | N/A | $85.87M |
| Revenue Est. Change | N/A | +6,909.93% |
| $3.28 | ||
| Price Target | - | $45.00 |
| Price Tgt. Change | - | +1,271.95% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.86 | -$2.36 | -27.25% | |
| -$1.42 | -$1.34 | +5.82% | |
| -$0.36 | N/A | +73.08% | |
| $0.50 | N/A | +137.39% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| $11.81M | $1.23M | -89.63% | |
| $85.87M | N/A | +6,909.93% | |
| $301.74M | N/A | +24,531.47% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +33.88% | ||
| -51.76% | ||
| +156.06% | ||
| +126.86% | ||
| +100.00% | ||
| +100.00% | ||
| +43.34% | ||
| +77.87% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $3.28 | ||
| $2.50 | ||
| SMA 200 vs Price | -23.64% | |
| $2.47 | ||
| SMA 50 vs Price | -24.63% | |
| 1.97 | ||
| $0.21 | ||
| 66.80 | ||
| 69.14% | ||
| 81.41% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $1.23M | ||
| -$1.34 | ||
| $577.00K | ||
| 47.10% | ||
| -$16.19M | ||
| -1,321.47% | ||
| -$28.62M | ||
| -2,336.49% | ||
| -$16.05M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -0.04 | ||
| 0.31 | ||
| 0.31 | ||
| - | ||
| - | ||
| -36.76 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 47.30 | ||
| -7.85 | ||
| -6.08 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$15.94M | ||
| $7.80M | ||
| $12.96M | ||
| $8.89M | ||
| $28.89M | ||
| $28.58M | ||
| $631.00K | ||
| $316.00K | ||
| $4.27M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $29.85M | ||
| $16.77M | ||
| $648.00K | ||
| $0.00 | ||
| $143.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$14.11M | ||
| -$2.81M | ||
| $23.28M | ||
| $0.00 | ||
| -$14.11M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| D. Boral Capital | → | |
| HC Wainwright & Co. | → | |
| Ascendiant Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| BTIG | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → |
Analyst sentiment
Institutional ownership
Screeners with NRXP
FAQ
What is the ticker symbol for NRx Pharmaceuticals, Inc.?
The ticker symbol for NRx Pharmaceuticals, Inc. is NASDAQ:NRXP
Does NRx Pharmaceuticals, Inc. pay dividends?
No, NRx Pharmaceuticals, Inc. does not pay dividends
What sector is NRx Pharmaceuticals, Inc. in?
NRx Pharmaceuticals, Inc. is in the Healthcare sector
What industry is NRx Pharmaceuticals, Inc. in?
NRx Pharmaceuticals, Inc. is in the Biotechnology industry
What country is NRx Pharmaceuticals, Inc. based in?
NRx Pharmaceuticals, Inc. is headquartered in United States
When did NRx Pharmaceuticals, Inc. go public?
NRx Pharmaceuticals, Inc. initial public offering (IPO) was on December 4, 2017
Is NRx Pharmaceuticals, Inc. in the S&P 500?
No, NRx Pharmaceuticals, Inc. is not included in the S&P 500 index
Is NRx Pharmaceuticals, Inc. in the NASDAQ 100?
No, NRx Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is NRx Pharmaceuticals, Inc. in the Dow Jones?
No, NRx Pharmaceuticals, Inc. is not included in the Dow Jones index
When was NRx Pharmaceuticals, Inc. last earnings report?
NRx Pharmaceuticals, Inc.'s most recent earnings report was on November 17, 2025
When does NRx Pharmaceuticals, Inc. report earnings?
The next expected earnings date for NRx Pharmaceuticals, Inc. is May 18, 2026
Data Sources & References
- NRXP Official Website www.nrxpharma.com
- NRXP Profile on Yahoo Finance finance.yahoo.com/quote/NRXP
- NRXP Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nrxp